US7375198B2
(en)
*
|
1993-10-26 |
2008-05-20 |
Affymetrix, Inc. |
Modified nucleic acid probes
|
US6475721B2
(en)
|
1995-03-04 |
2002-11-05 |
Boston Probes, Inc. |
Sequence specific detection of nucleic acids using a solid carrier bound with nucleic acid analog probes
|
GB9507238D0
(en)
*
|
1995-04-07 |
1995-05-31 |
Isis Innovation |
Detecting dna sequence variations
|
US6852487B1
(en)
*
|
1996-02-09 |
2005-02-08 |
Cornell Research Foundation, Inc. |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
US20020150921A1
(en)
*
|
1996-02-09 |
2002-10-17 |
Francis Barany |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
AU2320597A
(en)
|
1996-03-19 |
1997-10-10 |
Molecular Tool, Inc. |
Method for determining the nucleotide sequence of a polynucleotide
|
EP0912761A4
(de)
|
1996-05-29 |
2004-06-09 |
Cornell Res Foundation Inc |
Bestimmung von unterschieden in der nukleisäuresequenz mittels einer kombination von ligasebestimmung und polymerase-kettenreaktion
|
US6130038A
(en)
*
|
1996-07-16 |
2000-10-10 |
Gen-Probe Incorporated |
Method for amplifying target nucleic acids using modified primers
|
US7070925B1
(en)
|
1996-07-16 |
2006-07-04 |
Gen-Probe Incorporated |
Method for determining the presence of an RNA analyte in a sample using a modified oligonucleotide probe
|
US6361940B1
(en)
|
1996-09-24 |
2002-03-26 |
Qiagen Genomics, Inc. |
Compositions and methods for enhancing hybridization and priming specificity
|
CA2276462C
(en)
*
|
1996-12-31 |
2007-06-12 |
Genometrix Incorporated |
Multiplexed molecular analysis system apparatus and method
|
SE522077C2
(sv)
|
1997-09-05 |
2004-01-13 |
Lightup Technologies Ab |
Förfarande att välja sekvens hos sond för nukleinsyrahybridisering
|
US6518017B1
(en)
*
|
1997-10-02 |
2003-02-11 |
Oasis Biosciences Incorporated |
Combinatorial antisense library
|
US6989270B1
(en)
|
1997-10-17 |
2006-01-24 |
Mayo Foundation For Medical Education And Research |
Using polyamide nucleic acid oligomers to engender a biological response
|
US6723560B2
(en)
*
|
1998-10-08 |
2004-04-20 |
Mayo Foundation For Medical Education And Research |
Using polyamide nucleic acid oligomers to engender a biological response
|
US20100105572A1
(en)
*
|
1997-12-19 |
2010-04-29 |
Kris Richard M |
High throughput assay system
|
US20030096232A1
(en)
*
|
1997-12-19 |
2003-05-22 |
Kris Richard M. |
High throughput assay system
|
US20030039967A1
(en)
*
|
1997-12-19 |
2003-02-27 |
Kris Richard M. |
High throughput assay system using mass spectrometry
|
US6087102A
(en)
|
1998-01-07 |
2000-07-11 |
Clontech Laboratories, Inc. |
Polymeric arrays and methods for their use in binding assays
|
US6289229B1
(en)
|
1998-01-20 |
2001-09-11 |
Scimed Life Systems, Inc. |
Readable probe array for in vivo use
|
US20020090639A1
(en)
*
|
1998-02-26 |
2002-07-11 |
Mcginnis Ralph Evan |
Two dimensional linkage study methods and related inventions
|
US6077673A
(en)
*
|
1998-03-31 |
2000-06-20 |
Clontech Laboratories, Inc. |
Mouse arrays and kits comprising the same
|
US7715989B2
(en)
*
|
1998-04-03 |
2010-05-11 |
Elitech Holding B.V. |
Systems and methods for predicting oligonucleotide melting temperature (TmS)
|
US6683173B2
(en)
*
|
1998-04-03 |
2004-01-27 |
Epoch Biosciences, Inc. |
Tm leveling methods
|
IL138668A0
(en)
*
|
1998-04-03 |
2001-10-31 |
Phylos Inc |
Addressable protein arrays
|
US7875440B2
(en)
|
1998-05-01 |
2011-01-25 |
Arizona Board Of Regents |
Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
|
US6780591B2
(en)
|
1998-05-01 |
2004-08-24 |
Arizona Board Of Regents |
Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
|
US6979728B2
(en)
|
1998-05-04 |
2005-12-27 |
Baylor College Of Medicine |
Articles of manufacture and methods for array based analysis of biological molecules
|
WO2000001850A2
(en)
*
|
1998-07-02 |
2000-01-13 |
Gen-Probe Incorporated |
Molecular torches
|
US6222030B1
(en)
*
|
1998-08-03 |
2001-04-24 |
Agilent Technologies, Inc. |
Solid phase synthesis of oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection
|
US6461812B2
(en)
|
1998-09-09 |
2002-10-08 |
Agilent Technologies, Inc. |
Method and multiple reservoir apparatus for fabrication of biomolecular arrays
|
US6475440B1
(en)
|
1998-09-16 |
2002-11-05 |
Clontech Laboratories, Inc. |
Applicator for use in deposition of fluid samples onto a substrate surface
|
US6087112A
(en)
|
1998-12-30 |
2000-07-11 |
Oligos Etc. Inc. |
Arrays with modified oligonucleotide and polynucleotide compositions
|
US6506594B1
(en)
*
|
1999-03-19 |
2003-01-14 |
Cornell Res Foundation Inc |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
WO2000070093A1
(en)
*
|
1999-05-13 |
2000-11-23 |
Oligos Etc. Inc. |
Arrays with modified oligonucleotide and polynucleotide compositions
|
US6818395B1
(en)
|
1999-06-28 |
2004-11-16 |
California Institute Of Technology |
Methods and apparatus for analyzing polynucleotide sequences
|
KR100379411B1
(ko)
*
|
1999-06-28 |
2003-04-10 |
엘지전자 주식회사 |
바이오칩 및 그의 생체 물질 패터닝 및 측정 방법
|
US6346423B1
(en)
|
1999-07-16 |
2002-02-12 |
Agilent Technologies, Inc. |
Methods and compositions for producing biopolymeric arrays
|
EP1072679A3
(de)
*
|
1999-07-20 |
2002-07-31 |
Agilent Technologies, Inc. (a Delaware corporation) |
Methode zur Herstelung von Nucleinsäuremolekülen mit einer reduzierten Sekundärstruktur
|
US20050118618A1
(en)
*
|
1999-08-30 |
2005-06-02 |
Dale Roderic M. |
Method for detecting nucleic acid sequences
|
US7244559B2
(en)
|
1999-09-16 |
2007-07-17 |
454 Life Sciences Corporation |
Method of sequencing a nucleic acid
|
US7211390B2
(en)
|
1999-09-16 |
2007-05-01 |
454 Life Sciences Corporation |
Method of sequencing a nucleic acid
|
WO2001023620A2
(en)
*
|
1999-09-29 |
2001-04-05 |
Oligos Etc. Inc. |
Arrays with modified oligonucleotide and polynucleotide compositions
|
US6844151B1
(en)
|
1999-09-29 |
2005-01-18 |
Oligos Etc. Inc. |
Methods for production of arrays with modified oligonucleotide and polynucleotide compositions
|
US7332275B2
(en)
|
1999-10-13 |
2008-02-19 |
Sequenom, Inc. |
Methods for detecting methylated nucleotides
|
US6171797B1
(en)
|
1999-10-20 |
2001-01-09 |
Agilent Technologies Inc. |
Methods of making polymeric arrays
|
US6958225B2
(en)
|
1999-10-27 |
2005-10-25 |
Affymetrix, Inc. |
Complexity management of genomic DNA
|
US6660845B1
(en)
|
1999-11-23 |
2003-12-09 |
Epoch Biosciences, Inc. |
Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
|
WO2001038585A2
(en)
*
|
1999-11-24 |
2001-05-31 |
The Regents Of The University Of California |
Polymer arrays and methods of using labeled probe molecules to identify and quantify target molecule expression
|
EP1111069A1
(de)
*
|
1999-12-22 |
2001-06-27 |
BioChip Technologies GmbH |
Modifizierte Nukleinsäuren und deren Verwendung
|
US6800439B1
(en)
|
2000-01-06 |
2004-10-05 |
Affymetrix, Inc. |
Methods for improved array preparation
|
WO2001055451A1
(en)
*
|
2000-01-28 |
2001-08-02 |
Linden Technologies, Inc. |
C-3' protected monomeric nucleotides and synthesis of oligonucleotides on solid support
|
JP2003535588A
(ja)
*
|
2000-01-28 |
2003-12-02 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒト酵素及び該酵素をコードするポリヌクレオチド
|
US6833450B1
(en)
|
2000-03-17 |
2004-12-21 |
Affymetrix, Inc. |
Phosphite ester oxidation in nucleic acid array preparation
|
US6806361B1
(en)
|
2000-03-17 |
2004-10-19 |
Affymetrix, Inc. |
Methods of enhancing functional performance of nucleic acid arrays
|
WO2001075856A1
(en)
*
|
2000-03-31 |
2001-10-11 |
The Regents Of The University Of California |
Dna analysis software
|
CA2405412A1
(en)
|
2000-04-14 |
2001-10-25 |
Cornell Research Foundation, Inc. |
Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction
|
US20020028455A1
(en)
*
|
2000-05-03 |
2002-03-07 |
Laibinis Paul E. |
Methods and reagents for assembling molecules on solid supports
|
US20020120409A1
(en)
*
|
2000-05-19 |
2002-08-29 |
Affymetrix, Inc. |
Methods for gene expression analysis
|
EP1349954B1
(de)
|
2000-05-19 |
2011-01-26 |
Eragen Biosciences, Inc. |
Materialien und methoden zum nachweis von nukleinsäuren
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
CN101099745A
(zh)
|
2000-05-26 |
2008-01-09 |
艾登尼科斯(开曼)有限公司 |
处理黄病毒和瘟病毒的方法和组合物
|
US7005259B1
(en)
|
2000-06-01 |
2006-02-28 |
Affymetrix, Inc. |
Methods for array preparation using substrate rotation
|
EP1176151B1
(de)
|
2000-07-28 |
2014-08-20 |
Agilent Technologies, Inc. |
Synthese von Polynukleotiden unter Gebrauch von kombinierter Oxidations- und Entschützungschemie
|
US7238795B2
(en)
*
|
2000-08-03 |
2007-07-03 |
Roche Molecular Systems, Inc. |
Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
|
US20050272085A1
(en)
*
|
2000-09-06 |
2005-12-08 |
Hodge Timothy A |
Methods for forensic and congenic screening
|
US20030087286A1
(en)
*
|
2000-09-06 |
2003-05-08 |
Hodge Timothy A. |
Isolation of eukaryotic genomic DNA using magnetically responsive solid functionalized particles
|
US20030082605A1
(en)
*
|
2000-09-06 |
2003-05-01 |
Hodge Timothy A. |
Genomic DNA detection method and system thereof
|
EP1978110B1
(de)
*
|
2000-09-06 |
2010-05-26 |
Transnetyx, Inc. |
Computer-basiertes Verfahren und System zum Screenen von genomischer DNS
|
US20050266494A1
(en)
*
|
2000-09-06 |
2005-12-01 |
Hodge Timothy A |
System and method for computer network ordering of biological testing
|
US20050239125A1
(en)
*
|
2000-09-06 |
2005-10-27 |
Hodge Timothy A |
Methods for genotype screening
|
US7494817B2
(en)
*
|
2000-09-06 |
2009-02-24 |
Transnet Yx, Inc. |
Methods for genotype screening using magnetic particles
|
US20040185464A1
(en)
*
|
2000-09-15 |
2004-09-23 |
Kris Richard M. |
High throughput assay system
|
AU1317502A
(en)
|
2000-10-14 |
2002-04-29 |
Eragen Biosciences Inc |
Solid support assay systems and methods utilizing non-standard bases
|
CN100385013C
(zh)
*
|
2000-10-14 |
2008-04-30 |
伊拉根生物科学公司 |
使用非标准碱基的固相支持体分析系统和方法
|
US6849409B2
(en)
|
2000-10-16 |
2005-02-01 |
Axxima Pharmaceuticals Ag |
Cellular kinases involved in Cytomegalovirus infection and their inhibition
|
EP1368502A2
(de)
*
|
2001-02-13 |
2003-12-10 |
University of Rochester |
Alkynyliertes einzelstrang-oligonucleotid und seine verwendung
|
DE10112348A1
(de)
*
|
2001-03-13 |
2002-10-02 |
Antje Roetger |
Nukleotidträger zur Diagnose und Therapie oraler Erkrankungen
|
US20040038206A1
(en)
*
|
2001-03-14 |
2004-02-26 |
Jia Zhang |
Method for high throughput assay of genetic analysis
|
WO2002074979A2
(en)
*
|
2001-03-20 |
2002-09-26 |
Ortho-Clinical Diagnostics, Inc. |
Expression profiles and methods of use
|
US6986992B2
(en)
*
|
2001-03-30 |
2006-01-17 |
Amersham Biosciences Ab |
P450 single nucleotide polymorphism biochip analysis
|
EP1251183A3
(de)
*
|
2001-04-18 |
2003-12-10 |
Exiqon A/S |
Verbesserte Helfersonden zur Detektion einer Zielsequenz mittels Fangoligonukleotid
|
CN100334228C
(zh)
|
2001-06-21 |
2007-08-29 |
戴纳瓦克斯技术公司 |
嵌合免疫调制化合物及其使用方法
|
US7785610B2
(en)
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
US7264964B2
(en)
*
|
2001-06-22 |
2007-09-04 |
Ceres, Inc. |
Chimeric histone acetyltransferase polypeptides
|
JP4291143B2
(ja)
*
|
2001-08-31 |
2009-07-08 |
ジェン−プロウブ インコーポレイテッド |
分析物ポリヌクレオチドを定量するためのアフィニティーシフトしたプローブ
|
DE10142643A1
(de)
*
|
2001-08-31 |
2003-04-24 |
Clondiag Chip Tech Gmbh |
Detektion von Wechselwirkungen auf Sonden-Arrays
|
US20050147984A1
(en)
*
|
2001-08-31 |
2005-07-07 |
Clondiag Chip Technologies Gmbh |
Interaction detection on several probe arrays
|
KR100809679B1
(ko)
*
|
2001-09-01 |
2008-03-06 |
삼성전자주식회사 |
혼성화된 핵산의 검출 및 신호 증폭 방법
|
US20060014186A1
(en)
*
|
2001-09-04 |
2006-01-19 |
Hodge Timothy A |
Methods for genotype screening of a strain disposed on an adsorbent carrier
|
DE10152925A1
(de)
*
|
2001-10-26 |
2003-05-08 |
Febit Ag |
Asymmetrische Sonden
|
US6858720B2
(en)
|
2001-10-31 |
2005-02-22 |
Agilent Technologies, Inc. |
Method of synthesizing polynucleotides using ionic liquids
|
US6852850B2
(en)
|
2001-10-31 |
2005-02-08 |
Agilent Technologies, Inc. |
Use of ionic liquids for fabrication of polynucleotide arrays
|
US20040067512A1
(en)
*
|
2001-11-09 |
2004-04-08 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
|
US20110151438A9
(en)
|
2001-11-19 |
2011-06-23 |
Affymetrix, Inc. |
Methods of Analysis of Methylation
|
US20030211526A1
(en)
*
|
2002-02-15 |
2003-11-13 |
Jyh-Lyh Juang |
Cross-species nucleic acid probes
|
US20030162178A1
(en)
*
|
2002-02-25 |
2003-08-28 |
O'hagan David |
Variable microarray and methods of detecting one or more anlaytes in a sample
|
AU2003220159A1
(en)
*
|
2002-03-08 |
2003-09-22 |
Spectral Genomics, Inc. |
Articles of manufacture and methods for making hydrophobic derivatized arrays
|
US6916621B2
(en)
|
2002-03-27 |
2005-07-12 |
Spectral Genomics, Inc. |
Methods for array-based comparitive binding assays
|
US7687256B2
(en)
*
|
2002-04-11 |
2010-03-30 |
Spire Corporation |
Surface activated biochip
|
US20030198967A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Matson Robert S. |
Multi-functional microarrays and methods
|
EP1501863A4
(de)
*
|
2002-05-03 |
2007-01-24 |
Sequenom Inc |
Kinaseankerproteinmuteine, peptide davon und damit im zusammenhang stehende verfahren
|
AU2003237249A1
(en)
*
|
2002-05-24 |
2003-12-12 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
CN101172993A
(zh)
|
2002-06-28 |
2008-05-07 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
|
RS113904A
(en)
|
2002-06-28 |
2007-02-05 |
Idenix (Cayman) Limited |
2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
FR2842827B1
(fr)
*
|
2002-07-26 |
2004-10-22 |
Biocortech |
NOUVELLE METHODE D'ANALYSE D'ACIDE NUCLEIQUE ET SON UTILISATION POUR EVALUER LE DEGRE D'EDITION DE L'ARNm DU RECEPTEUR 5-HT2c
|
US7508608B2
(en)
|
2004-11-17 |
2009-03-24 |
Illumina, Inc. |
Lithographically fabricated holographic optical identification element
|
US7901630B2
(en)
|
2002-08-20 |
2011-03-08 |
Illumina, Inc. |
Diffraction grating-based encoded microparticle assay stick
|
US7872804B2
(en)
|
2002-08-20 |
2011-01-18 |
Illumina, Inc. |
Encoded particle having a grating with variations in the refractive index
|
US7923260B2
(en)
|
2002-08-20 |
2011-04-12 |
Illumina, Inc. |
Method of reading encoded particles
|
US7900836B2
(en)
|
2002-08-20 |
2011-03-08 |
Illumina, Inc. |
Optical reader system for substrates having an optically readable code
|
US7164533B2
(en)
|
2003-01-22 |
2007-01-16 |
Cyvera Corporation |
Hybrid random bead/chip based microarray
|
US20060147924A1
(en)
*
|
2002-09-11 |
2006-07-06 |
Ramsing Neils B |
Population of nucleic acids including a subpopulation of lna oligomers
|
US20100255603A9
(en)
|
2002-09-12 |
2010-10-07 |
Putnam Martin A |
Method and apparatus for aligning microbeads in order to interrogate the same
|
US7092160B2
(en)
|
2002-09-12 |
2006-08-15 |
Illumina, Inc. |
Method of manufacturing of diffraction grating-based optical identification element
|
US20040219565A1
(en)
*
|
2002-10-21 |
2004-11-04 |
Sakari Kauppinen |
Oligonucleotides useful for detecting and analyzing nucleic acids of interest
|
DE60331587D1
(de)
*
|
2002-11-15 |
2010-04-15 |
Gen Probe Inc |
Test und zusammensetzungen zum nachweis von bacillus-anthracis-nukleinsäure
|
HUE033832T2
(en)
|
2002-11-15 |
2018-01-29 |
Idenix Pharmaceuticals Llc |
2'-methyl nucleosides in combination with interferon and Flaviviridae mutation
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
US7598373B2
(en)
|
2002-12-12 |
2009-10-06 |
Idenix Pharmaceuticals, Inc. |
Process for the production of 2-C-methyl-D-ribonolactone
|
EP1590482B1
(de)
|
2003-01-17 |
2008-12-10 |
Eragen Biosciences, Inc. |
Nukleinsäureamplifikation mit nichtstandardbasen
|
WO2004078941A2
(en)
*
|
2003-03-06 |
2004-09-16 |
Oligo Engine, Inc. |
Modulation of gene expression using dna-rna hybrids
|
AU2004227353B2
(en)
|
2003-04-01 |
2010-02-25 |
Luminex Corporation |
Polymerase inhibitor and method of using same
|
CA2463719A1
(en)
*
|
2003-04-05 |
2004-10-05 |
F. Hoffmann-La Roche Ag |
Nucleotide analogs with six membered rings
|
US20040219532A1
(en)
*
|
2003-04-30 |
2004-11-04 |
Sampson Jeffrey R. |
Internal references measurements
|
JP2004337042A
(ja)
*
|
2003-05-14 |
2004-12-02 |
Canon Inc |
核酸アレイ
|
KR100883703B1
(ko)
|
2003-05-30 |
2009-02-12 |
파마셋 인코포레이티드 |
변형 불소화 뉴클레오시드 유사체
|
US20050064462A1
(en)
*
|
2003-06-17 |
2005-03-24 |
Bernd Stein |
Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms
|
WO2004111266A1
(en)
*
|
2003-06-17 |
2004-12-23 |
Human Genetic Signatures Pty Ltd |
Methods for genome amplification
|
US20040259100A1
(en)
|
2003-06-20 |
2004-12-23 |
Illumina, Inc. |
Methods and compositions for whole genome amplification and genotyping
|
US7642064B2
(en)
*
|
2003-06-24 |
2010-01-05 |
Ventana Medical Systems, Inc. |
Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest
|
CA2537810C
(en)
*
|
2003-09-04 |
2012-12-18 |
Human Genetic Signatures Pty Ltd |
Nucleic acid detection assay
|
GB0324851D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Expresson Biosystems Ltd |
Short biological polymers on solid supports
|
WO2005040163A1
(en)
*
|
2003-10-28 |
2005-05-06 |
Dr. Reddy's Laboratories Ltd |
Heterocyclic compounds that block the effects of advanced glycation end products (age)
|
US7169560B2
(en)
|
2003-11-12 |
2007-01-30 |
Helicos Biosciences Corporation |
Short cycle methods for sequencing polynucleotides
|
EP2248911A1
(de)
|
2004-02-19 |
2010-11-10 |
Helicos Biosciences Corporation |
Verfahren und Zusammensetzungen zur Analyse von Polynukleotidsequenzen
|
US7433123B2
(en)
|
2004-02-19 |
2008-10-07 |
Illumina, Inc. |
Optical identification element having non-waveguide photosensitive substrate with diffraction grating therein
|
US8168777B2
(en)
|
2004-04-29 |
2012-05-01 |
Human Genetic Signatures Pty. Ltd. |
Bisulphite reagent treatment of nucleic acid
|
US7702466B1
(en)
|
2004-06-29 |
2010-04-20 |
Illumina, Inc. |
Systems and methods for selection of nucleic acid sequence probes
|
JP4476050B2
(ja)
*
|
2004-06-30 |
2010-06-09 |
株式会社ニデック |
視野計
|
ATE466107T1
(de)
|
2004-07-01 |
2010-05-15 |
Gen Probe Inc |
Verfahren und zusammensetzungen zum nachweis von nukleinsäuren in einer biologischen probe
|
WO2006020363A2
(en)
|
2004-07-21 |
2006-02-23 |
Illumina, Inc. |
Method and apparatus for drug product tracking using encoded optical identification elements
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
CA2574610A1
(en)
*
|
2004-07-22 |
2006-03-02 |
Sequenom, Inc. |
Methods for identifying risk of type ii diabetes and treatments thereof
|
SI3109244T1
(sl)
|
2004-09-14 |
2019-06-28 |
Gilead Pharmasset Llc |
Priprava 2'fluoro-2'-alkil-substituiranih ali drugih neobvezno substituiranih ribofuranozil pirimidinov in purinov in njihovih derivatov
|
US8969379B2
(en)
|
2004-09-17 |
2015-03-03 |
Eisai R&D Management Co., Ltd. |
Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide
|
US20060073511A1
(en)
|
2004-10-05 |
2006-04-06 |
Affymetrix, Inc. |
Methods for amplifying and analyzing nucleic acids
|
WO2006055736A1
(en)
|
2004-11-16 |
2006-05-26 |
Illumina, Inc. |
And methods and apparatus for reading coded microbeads
|
EP1828411B1
(de)
*
|
2004-12-03 |
2012-11-07 |
Human Genetic Signatures PTY Ltd |
Verfahren zur vereinfachung mikrobieller nukleinsäuren durch chemische modifikation von cytosinen
|
CN101142323A
(zh)
*
|
2004-12-23 |
2008-03-12 |
人类遗传标记控股有限公司 |
人类乳头瘤病毒的检测
|
KR20070095452A
(ko)
*
|
2005-01-25 |
2007-09-28 |
스카이 제네틱스, 인코포레이티드 |
암 세포의 세포자멸사를 위한 핵산
|
US20060183893A1
(en)
*
|
2005-01-25 |
2006-08-17 |
North Don A |
Nucleic acids for apoptosis of cancer cells
|
WO2006089045A2
(en)
|
2005-02-18 |
2006-08-24 |
Monogram Biosciences, Inc. |
Methods and compositions for determining hypersusceptibility of hiv-1 to non-nucleoside reverse transcriptase inhibitors
|
WO2006089046A2
(en)
|
2005-02-18 |
2006-08-24 |
Monogram Biosciences, Inc. |
Methods and compositions for determining anti-hiv drug susceptibility and replication capacity of hiv
|
JP4516863B2
(ja)
*
|
2005-03-11 |
2010-08-04 |
株式会社ケンウッド |
音声合成装置、音声合成方法及びプログラム
|
WO2006101913A2
(en)
|
2005-03-18 |
2006-09-28 |
Eragen Biosciences, Inc. |
Methods for detecting multiple species and subspecies of neiserria
|
JP2008541705A
(ja)
*
|
2005-05-26 |
2008-11-27 |
ヒューマン ジェネティック シグネチャーズ ピーティーワイ リミテッド |
非標準塩基を含むプライマーを使用する等温鎖置換増幅
|
EP2458018A3
(de)
|
2005-05-27 |
2012-07-25 |
Monogram BioSciences, Inc. |
Verfahren und Zusammensetzungen zum Bestimmen der HIV-1-Beständigkeit gegenüber Proteasehemmern
|
WO2006133267A2
(en)
*
|
2005-06-06 |
2006-12-14 |
Monogram Biosciences, Inc. |
Methods and compositions for determining altered susceptibility of hiv-1 to anti-hiv drugs
|
WO2006133266A2
(en)
|
2005-06-06 |
2006-12-14 |
Monogram Biosciences, Inc. |
Methods for determining resistance or susceptibility to hiv entry inhibitors
|
WO2006133184A2
(en)
*
|
2005-06-07 |
2006-12-14 |
Eragen Biosciences, Inc. |
Methods for detection and typing of nucleic acids
|
SG162795A1
(en)
|
2005-06-15 |
2010-07-29 |
Callida Genomics Inc |
Single molecule arrays for genetic and chemical analysis
|
US20060292585A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Affymetrix, Inc. |
Analysis of methylation using nucleic acid arrays
|
US9006240B2
(en)
*
|
2005-08-02 |
2015-04-14 |
Eisai R&D Management Co., Ltd. |
Method for assay on the effect of vascularization inhibitor
|
US7666593B2
(en)
|
2005-08-26 |
2010-02-23 |
Helicos Biosciences Corporation |
Single molecule sequencing of captured nucleic acids
|
ATE531820T1
(de)
*
|
2005-09-14 |
2011-11-15 |
Human Genetic Signatures Pty |
Gesundheitszustandstest
|
US20070202515A1
(en)
*
|
2005-10-12 |
2007-08-30 |
Pathologica, Llc. |
Promac signature application
|
CN101316590B
(zh)
|
2005-11-07 |
2011-08-03 |
卫材R&D管理有限公司 |
血管生成抑制剂和c-kit激酶抑制剂的组合使用
|
CA2634749C
(en)
|
2005-12-23 |
2014-08-19 |
Idenix Pharmaceuticals, Inc. |
Process for preparing a synthetic intermediate for preparation of branched nucleosides
|
SG134283A1
(en)
*
|
2006-01-24 |
2007-08-29 |
Ind Tech Res Inst |
Biomarkers for liver fibrotic injury
|
US20080045471A1
(en)
*
|
2006-03-27 |
2008-02-21 |
North Don A |
Nucleic Acids For Apoptosis Of Cancer Cells
|
US7901882B2
(en)
|
2006-03-31 |
2011-03-08 |
Affymetrix, Inc. |
Analysis of methylation using nucleic acid arrays
|
US7830575B2
(en)
|
2006-04-10 |
2010-11-09 |
Illumina, Inc. |
Optical scanner with improved scan time
|
RU2448708C3
(ru)
|
2006-05-18 |
2017-09-28 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Противоопухолевое средство против рака щитовидной железы
|
US20080050738A1
(en)
*
|
2006-05-31 |
2008-02-28 |
Human Genetic Signatures Pty Ltd. |
Detection of target nucleic acid
|
WO2007140417A2
(en)
|
2006-05-31 |
2007-12-06 |
Sequenom, Inc. |
Methods and compositions for the extraction and amplification of nucleic acid from a sample
|
US8153369B2
(en)
|
2006-06-05 |
2012-04-10 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
JP5368096B2
(ja)
|
2006-08-28 |
2013-12-18 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
未分化型胃癌に対する抗腫瘍剤
|
WO2008066655A2
(en)
|
2006-11-02 |
2008-06-05 |
Yale University |
Assessment of oocyte competence
|
DK2099935T3
(da)
*
|
2006-11-30 |
2014-04-07 |
Univ California |
Array for detektion af mikrober
|
US7902345B2
(en)
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
DE102007018833A1
(de)
|
2007-04-20 |
2008-10-23 |
Febit Holding Gmbh |
Verbesserte molekularbiologische Prozessanlage
|
DE102006062089A1
(de)
|
2006-12-29 |
2008-07-03 |
Febit Holding Gmbh |
Verbesserte molekularbiologische Prozessanlage
|
KR101445892B1
(ko)
|
2007-01-29 |
2014-09-29 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
미분화형 위암 치료용 조성물
|
AU2008213634B2
(en)
|
2007-02-08 |
2013-09-05 |
Sequenom, Inc. |
Nucleic acid-based tests for RhD typing, gender determination and nucleic acid quantification
|
US9581595B2
(en)
|
2007-02-26 |
2017-02-28 |
Laboratory Corporation Of America Holdings |
Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy
|
CA2679954A1
(en)
|
2007-03-05 |
2008-09-12 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
CA2680426A1
(en)
*
|
2007-03-16 |
2008-09-25 |
Human Genetic Signatures Pty Ltd |
Assay for gene expression
|
AU2008230813B2
(en)
|
2007-03-26 |
2014-01-30 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
JP5719591B2
(ja)
|
2007-06-08 |
2015-05-20 |
バイオジェン アイデック エムエー インコーポレイティドBiogen Idec Inc. |
抗tnf応答性または非応答性を予測するためのバイオマーカー
|
EP2195452B1
(de)
|
2007-08-29 |
2012-03-14 |
Sequenom, Inc. |
Verfahren und zusammensetzungen für die universelle grössenspezifische polymerasekettenreaktion
|
KR101513326B1
(ko)
*
|
2007-11-09 |
2015-04-17 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
혈관 신생 저해 물질과 항종양성 백금 착물의 병용
|
EP2215250B1
(de)
|
2007-11-27 |
2013-02-27 |
Human Genetic Signatures Pty Ltd |
Enzyme zur amplifikation und zum kopieren bisulphit-modifizierter nukleinsäuren
|
JP2011505845A
(ja)
*
|
2007-12-20 |
2011-03-03 |
ヒューマン ジェネティック シグネチャーズ ピーティーワイ リミテッド |
核酸増幅に伴う汚染物質の排除
|
WO2009114543A2
(en)
|
2008-03-11 |
2009-09-17 |
Sequenom, Inc. |
Nucleic acid-based tests for prenatal gender determination
|
AU2009228312B2
(en)
|
2008-03-26 |
2015-05-21 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
EP2105465A1
(de)
*
|
2008-03-27 |
2009-09-30 |
Greene, Tweed Of Delaware, Inc. |
An ein inertes Substrat gebundene Perfluorelastomer-Bestandteile und zugehörige Verfahren
|
WO2009121021A1
(en)
*
|
2008-03-28 |
2009-10-01 |
Life Technologies Corporation |
Degradable arrays for preventing reuse
|
US20090269746A1
(en)
*
|
2008-04-25 |
2009-10-29 |
Gil Atzmon |
Microsequencer-whole genome sequencer
|
CA2723726C
(en)
|
2008-05-13 |
2017-09-12 |
Michael M. Becker |
Inactivatable target capture oligomers for use in the selective hybridization and capture of target nucleic acid sequences
|
US20110111417A1
(en)
|
2008-05-14 |
2011-05-12 |
Millennium Pharmaceuticals, Inc. |
Methods and kits for monitoring the effects of immunomodulators on adaptive immunity
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
US8470164B2
(en)
|
2008-06-25 |
2013-06-25 |
Life Technologies Corporation |
Methods and apparatus for measuring analytes using large scale FET arrays
|
ES2581774T3
(es)
|
2008-08-29 |
2016-09-07 |
Janssen Biotech, Inc. |
Marcadores y métodos de evaluación y tratamiento de colitis ulcerosa y trastornos relacionados mediante un panel de 20 genes
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
EP2352998A4
(de)
|
2008-11-07 |
2011-09-21 |
Centocor Ortho Biotech Inc |
Marker und verfahren zur untersuchung und behandlung von lichtreizempfindlichen lupus-patienten
|
EP2367958B1
(de)
|
2008-11-25 |
2017-08-23 |
Gen-Probe Incorporated |
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR ERKENNUNG VON sRNA UND IHRE VERWENDUNG
|
NZ617066A
(en)
|
2008-12-23 |
2015-02-27 |
Gilead Pharmasset Llc |
Nucleoside analogs
|
CA2748057C
(en)
|
2008-12-23 |
2018-07-03 |
Pharmasset, Inc. |
Nucleoside phosphoramidates
|
EP2671888A1
(de)
|
2008-12-23 |
2013-12-11 |
Gilead Pharmasset LLC |
3',5'-zyklische Nucleosidphosphatanaloga
|
EP3211095B1
(de)
|
2009-04-03 |
2019-01-02 |
Sequenom, Inc. |
Zusammensetzungen und verfahren für die herstellung von nukleinsäuren
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
AU2010276236B2
(en)
|
2009-07-21 |
2014-03-20 |
Gen-Probe Incorporated |
Methods and compositions for quantitative detection of nucleic acid sequences over an extended dynamic range
|
US8440406B2
(en)
|
2009-10-23 |
2013-05-14 |
Luminex Corporation |
Amplification primers with non-standard bases for increased reaction specificity
|
US9926593B2
(en)
|
2009-12-22 |
2018-03-27 |
Sequenom, Inc. |
Processes and kits for identifying aneuploidy
|
WO2011079280A2
(en)
|
2009-12-23 |
2011-06-30 |
Hill's Pet Nutrition, Inc. |
Compositions and methods for diagnosing and treating kidney disorders in a canine
|
CL2011000716A1
(es)
|
2010-03-31 |
2012-04-20 |
Gilead Pharmasset Llc |
Formas cristalinas 1 6 de (s)-isopropil-2-(((s)-(((2r.3r.4r.5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-4-fluoro-3-hidroxi-4-metil tetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato; composicion y combinacion farmaceutica; y su uso para tratar una infeccion por el virus de la hepatitis c.
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
WO2011146725A1
(en)
|
2010-05-19 |
2011-11-24 |
Bayer Healthcare Llc |
Biomarkers for a multikinase inhibitor
|
WO2011159942A1
(en)
|
2010-06-18 |
2011-12-22 |
Illumina, Inc. |
Conformational probes and methods for sequencing nucleic acids
|
MX2012014776A
(es)
|
2010-06-25 |
2013-01-29 |
Eisai R&D Man Co Ltd |
Agente antitumoral que emplea compuestos con efecto inhibidor de cinasas combinados.
|
JP6012605B2
(ja)
|
2010-09-22 |
2016-10-25 |
アリオス バイオファーマ インク. |
置換されたヌクレオチドアナログ
|
WO2012058532A2
(en)
|
2010-10-28 |
2012-05-03 |
Yale University |
Methods and compositions for assessing and treating cancer
|
US9308255B2
(en)
|
2010-11-24 |
2016-04-12 |
Yale University |
Methods of administering D-dopachrome tautomerase (D-DT) to treat ischemia-reperfusion injury
|
AU2011336632B2
(en)
|
2010-11-30 |
2015-09-03 |
Gilead Pharmasset Llc |
Compounds
|
EP3062108B1
(de)
|
2011-02-24 |
2019-06-19 |
Hill's Pet Nutrition, Inc. |
Verfahren zur diagnostizierung von nierenerkrankungen bei katzen
|
KR101762999B1
(ko)
|
2011-04-18 |
2017-07-28 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
종양 치료제
|
EP2699903B1
(de)
|
2011-04-20 |
2018-07-18 |
Life Technologies Corporation |
Verfahren, zusammensetzungen und systeme zur probenablagerung
|
WO2012149339A2
(en)
|
2011-04-29 |
2012-11-01 |
Sequenom, Inc. |
Quantification of a minority nucleic acid species
|
ES2705950T3
(es)
|
2011-06-03 |
2019-03-27 |
Eisai R&D Man Co Ltd |
Biomarcadores para predecir y valorar la capacidad de respuesta de sujetos con cáncer de tiroides y de riñón a compuestos de lenvatinib
|
AU2012271528B2
(en)
|
2011-06-15 |
2015-06-25 |
Hill's Pet Nutrition, Inc. |
Compositions and methods for diagnosing and monitoring hyperthyroidism in a feline
|
NZ622418A
(en)
|
2011-09-07 |
2014-12-24 |
Human Genetic Signatures Pty |
Molecular detection assay
|
ES2776144T3
(es)
|
2011-10-28 |
2020-07-29 |
Millennium Pharm Inc |
Biomarcadores de respuesta a inhibidores de NAE
|
CA2855368A1
(en)
|
2011-11-11 |
2013-05-16 |
Millennium Pharmaceuticals, Inc. |
Biomarkers of response to proteasome inhibitors
|
CN104039328B
(zh)
|
2011-11-11 |
2018-10-09 |
米伦纽姆医药公司 |
对蛋白酶体抑制剂的反应的生物标记
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
US20150038358A1
(en)
|
2011-12-01 |
2015-02-05 |
University Of Kansas |
Methods for detecting trisomy 21
|
WO2013087789A1
(en)
|
2011-12-13 |
2013-06-20 |
Glykos Finland Ltd. |
Antibody isoform arrays and methods thereof
|
JP6189857B2
(ja)
|
2011-12-19 |
2017-08-30 |
ヒルズ・ペット・ニュートリシャン・インコーポレーテッド |
伴侶動物において甲状腺機能亢進症を診断および治療するための組成物および方法
|
AU2012358804B2
(en)
|
2011-12-22 |
2018-04-19 |
Alios Biopharma, Inc. |
Substituted phosphorothioate nucleotide analogs
|
ES2930180T3
(es)
|
2012-03-02 |
2022-12-07 |
Sequenom Inc |
Métodos para enriquecer ácido nucleico canceroso a partir de una muestra biológica
|
NZ631601A
(en)
|
2012-03-21 |
2016-06-24 |
Alios Biopharma Inc |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
NZ630805A
(en)
|
2012-03-22 |
2016-01-29 |
Alios Biopharma Inc |
Pharmaceutical combinations comprising a thionucleotide analog
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
US9012022B2
(en)
|
2012-06-08 |
2015-04-21 |
Illumina, Inc. |
Polymer coatings
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
ES2905360T3
(es)
|
2012-07-16 |
2022-04-08 |
Univ Yale |
Composiciones y métodos para detectar, tratar y prevenir enfermedades y trastornos
|
CA2886783A1
(en)
|
2012-10-01 |
2014-04-10 |
Millennium Pharmaceuticals, Inc. |
Biomarkers and methods to predict response to inhibitors and uses thereof
|
KR102161331B1
(ko)
|
2012-11-28 |
2020-09-29 |
머크 샤프 앤드 돔 코포레이션 |
암을 치료하기 위한 조성물 및 방법
|
CN104755463A
(zh)
|
2012-12-21 |
2015-07-01 |
卫材R&D管理有限公司 |
非晶态形式的喹啉衍生物及其生产方法
|
US9896728B2
(en)
|
2013-01-29 |
2018-02-20 |
Arcticrx Ltd. |
Method for determining a therapeutic approach for the treatment of age-related macular degeneration (AMD)
|
WO2014126965A2
(en)
|
2013-02-13 |
2014-08-21 |
Yale University |
Compositions and methods for treating pathological calcification and ossification
|
EP3597774A1
(de)
|
2013-03-13 |
2020-01-22 |
Sequenom, Inc. |
Primer zur analyse der dna-methylierung
|
DK2970356T3
(en)
|
2013-03-15 |
2018-08-27 |
Illumina Cambridge Ltd |
Modified nucleosides or nucleotides
|
KR102204279B1
(ko)
|
2013-05-14 |
2021-01-15 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
자궁내막암 대상의 렌바티닙 화합물에 대한 반응성을 예측 및 평가하기 위한 생체표지
|
PL3017065T3
(pl)
|
2013-07-01 |
2019-03-29 |
Illumina, Inc. |
Funkcjonalizacja powierzchni i szczepienie polimeru bez użycia katalizatora
|
US10093978B2
(en)
|
2013-08-12 |
2018-10-09 |
Genentech, Inc. |
Compositions for detecting complement factor H (CFH) and complement factor I (CFI) polymorphisms
|
EP4005560A1
(de)
|
2013-08-27 |
2022-06-01 |
Gilead Pharmasset LLC |
Kombinationsformulierung von zwei antiviralen verbindungen
|
CN106132555B
(zh)
|
2013-11-11 |
2019-07-26 |
生命科技股份有限公司 |
转子组合件及其使用方法
|
EP3084003A4
(de)
|
2013-12-17 |
2017-07-19 |
Merck Sharp & Dohme Corp. |
Ifn-gamma-gensignaturbiomarker der tumorreaktion auf pd-1 antagonisten
|
CN114089597A
(zh)
|
2013-12-19 |
2022-02-25 |
Illumina公司 |
包括纳米图案化表面的基底及其制备方法
|
WO2015120280A1
(en)
|
2014-02-08 |
2015-08-13 |
Genentech, Inc. |
Methods of treating alzheimer's disease
|
EP3736344A1
(de)
|
2014-03-13 |
2020-11-11 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
ES2902484T3
(es)
|
2014-05-16 |
2022-03-28 |
Univ Yale |
Composiciones para el tratamiento y la prevención de la pancreatitis y las lesiones renales
|
GB201414098D0
(en)
|
2014-08-08 |
2014-09-24 |
Illumina Cambridge Ltd |
Modified nucleotide linkers
|
US9982250B2
(en)
|
2014-08-21 |
2018-05-29 |
Illumina Cambridge Limited |
Reversible surface functionalization
|
MX2017001980A
(es)
|
2014-08-28 |
2017-05-04 |
Eisai R&D Man Co Ltd |
Derivado de quinolina muy puro y metodo para su produccion.
|
PT3212684T
(pt)
|
2014-10-31 |
2020-02-03 |
Illumina Cambridge Ltd |
Revestimentos de polímeros e de copolímero de dna
|
US11377693B2
(en)
|
2014-12-09 |
2022-07-05 |
Merck Sharp & Dohme Llc |
System and methods for deriving gene signature biomarkers of response to PD-1 antagonists
|
CN107428818A
(zh)
|
2015-01-29 |
2017-12-01 |
密西根州立大学校董会 |
隐藏多肽及其用途
|
LT3263106T
(lt)
|
2015-02-25 |
2024-01-10 |
Eisai R&D Management Co., Ltd. |
Chinolino darinių kartumo sumažinimo būdas
|
MA41629A
(fr)
|
2015-03-04 |
2018-01-09 |
Center For Human Reproduction |
Compositions et méthodes d'utilisation de l'hormone anti-müllérienne pour le traitement de l'infertilité
|
AU2015384801B2
(en)
|
2015-03-04 |
2022-01-06 |
Eisai R&D Management Co., Ltd. |
Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer
|
US11326211B2
(en)
|
2015-04-17 |
2022-05-10 |
Merck Sharp & Dohme Corp. |
Blood-based biomarkers of tumor sensitivity to PD-1 antagonists
|
AU2016264364B2
(en)
|
2015-05-19 |
2022-06-23 |
Yale University |
Compositions for treating pathological calcification conditions, and methods using same
|
CN107801379B
(zh)
|
2015-06-16 |
2021-05-25 |
卫材R&D管理有限公司 |
抗癌剂
|
US20180207920A1
(en)
|
2015-07-17 |
2018-07-26 |
Illumina, Inc. |
Polymer sheets for sequencing applications
|
US20180305748A1
(en)
|
2015-10-18 |
2018-10-25 |
Affymetrix, Inc. |
Multiallelic Genotyping of Single Nucleotide Polymorphisms and Indels
|
JP7023842B2
(ja)
|
2015-10-29 |
2022-02-22 |
テンプル ユニヴァーシティ - オブ ザ コモンウェルス システム オブ ハイアー エデュケーション |
Dnaポリメラーゼシータによる核酸の3’末端の修飾
|
CA3005142A1
(en)
|
2015-11-20 |
2017-05-26 |
Yale University |
Compositions for treating ectopic calcification disorders, and methods using same
|
KR102171865B1
(ko)
|
2016-05-18 |
2020-10-29 |
일루미나, 인코포레이티드 |
패턴화된 소수성 표면을 사용한 자가 조립된 패터닝
|
WO2018098241A1
(en)
|
2016-11-22 |
2018-05-31 |
University Of Rochester |
Methods of assessing risk of recurrent prostate cancer
|
EP3615934A1
(de)
|
2017-04-28 |
2020-03-04 |
Merck Sharp & Dohme Corp. |
Biomarker für krebstherapeutika
|
WO2018213690A1
(en)
|
2017-05-18 |
2018-11-22 |
The Rockefeller University |
Compositions and methods for diagnosing and treating diseases and disorders associated with mutant kcnj5
|
WO2019109016A1
(en)
|
2017-12-01 |
2019-06-06 |
Millennium Pharmaceuticals, Inc. |
Biomarkers and methods for treatment with nae inhibitors
|
US20190211098A1
(en)
|
2017-12-22 |
2019-07-11 |
Genentech, Inc. |
Use of pilra binding agents for treatment of a disease
|
CN112567246A
(zh)
|
2018-01-25 |
2021-03-26 |
比奥根Ma公司 |
治疗脊髓性肌萎缩症的方法
|
GB201803240D0
(en)
|
2018-02-28 |
2018-04-11 |
Synpromics Ltd |
Methods and compositions for enriching nucleic acids
|
JP2022512590A
(ja)
|
2018-10-05 |
2022-02-07 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ソラフェニブ化合物を含む療法のためのバイオマーカー
|
JP7431226B2
(ja)
|
2018-10-05 |
2024-02-14 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
レンバチニブ及びエベロリムスを含む併用療法のためのバイオマーカー
|
US11293061B2
(en)
|
2018-12-26 |
2022-04-05 |
Illumina Cambridge Limited |
Sequencing methods using nucleotides with 3′ AOM blocking group
|
MA54949A
(fr)
|
2019-02-12 |
2021-12-22 |
Biogen Ma Inc |
Biomarqueurs de la leucoencéphalopathie multifocale progressive
|
US11421271B2
(en)
|
2019-03-28 |
2022-08-23 |
Illumina Cambridge Limited |
Methods and compositions for nucleic acid sequencing using photoswitchable labels
|
GB201916884D0
(en)
|
2019-11-20 |
2020-01-01 |
Evox Therapeutics Ltd |
Nanoparticle-like delivery system
|
CA3177293A1
(en)
|
2020-06-22 |
2021-12-30 |
Illumina Cambridge Limited |
Nucleosides and nucleotides with 3' acetal blocking group
|
GB202010278D0
(en)
|
2020-07-03 |
2020-08-19 |
Evox Therapeutics Ltd |
Extracellular vesicles with improved half-life
|
US20220033900A1
(en)
|
2020-07-28 |
2022-02-03 |
Illumina Cambridge Limited |
Substituted coumarin dyes and uses as fluorescent labels
|
IL302517A
(en)
|
2020-11-02 |
2023-07-01 |
Simcha Il 18 Inc |
Variants of interleukin-18 and methods of use
|
US20220195517A1
(en)
|
2020-12-17 |
2022-06-23 |
Illumina Cambridge Limited |
Long stokes shift chromenoquinoline dyes and uses in sequencing applications
|
US20220195196A1
(en)
|
2020-12-17 |
2022-06-23 |
Illumina Cambridge Limited |
Alkylpyridinium coumarin dyes and uses in sequencing applications
|
US20220195516A1
(en)
|
2020-12-17 |
2022-06-23 |
Illumina Cambridge Limited |
Methods, systems and compositions for nucleic acid sequencing
|
US20220195518A1
(en)
|
2020-12-22 |
2022-06-23 |
Illumina Cambridge Limited |
Methods and compositions for nucleic acid sequencing
|
GB2603203A
(en)
|
2021-02-02 |
2022-08-03 |
Univ Heriot Watt |
Method for enriching nucelic acids
|
GB202105925D0
(en)
|
2021-04-26 |
2021-06-09 |
Evox Therapeutics Ltd |
Modified extracellular vesicles (EVs) with improved half-life
|
KR20240004502A
(ko)
|
2021-05-05 |
2024-01-11 |
일루미나 케임브리지 리미티드 |
비스-붕소 융합 헤테로사이클을 함유하는 형광 염료 및 서열분석에서의 용도
|
GB202107182D0
(en)
|
2021-05-19 |
2021-06-30 |
Evox Therapeutics Ltd |
Nanoparticle delivery system for production of engineered extracellular vesicles
|
EP4341434A1
(de)
|
2021-05-20 |
2024-03-27 |
Illumina, Inc. |
Zusammensetzungen und verfahren zur sequenzierung durch synthese
|
CN117677435A
(zh)
|
2021-06-15 |
2024-03-08 |
伊鲁米纳公司 |
用于测序的不含水凝胶的表面官能化
|
WO2023004357A1
(en)
|
2021-07-23 |
2023-01-26 |
Illumina, Inc. |
Methods for preparing substrate surface for dna sequencing
|
WO2023069927A1
(en)
|
2021-10-20 |
2023-04-27 |
Illumina, Inc. |
Methods for capturing library dna for sequencing
|
GB202118946D0
(en)
|
2021-12-23 |
2022-02-09 |
Evox Therapeutics Ltd |
Engineered extracellular vesicles with improved cargo delivery
|
US20230330659A1
(en)
|
2022-03-22 |
2023-10-19 |
Illumina Cambridge Limited |
Substrate with orthogonally functional nanodomains
|
US20230304086A1
(en)
|
2022-03-28 |
2023-09-28 |
Illumina Cambridge Limited |
Labeled avidin and methods for sequencing
|
CA3223125A1
(en)
|
2022-03-29 |
2023-10-05 |
Illumina, Inc. |
Chromenoquinoline dyes and uses in sequencing
|
WO2023213979A1
(en)
|
2022-05-06 |
2023-11-09 |
Evox Therapeutics Limited |
Tspan2 as scaffold protein for engineered extracellular vesicles
|
WO2023232829A1
(en)
|
2022-05-31 |
2023-12-07 |
Illumina, Inc |
Compositions and methods for nucleic acid sequencing
|
US20230416279A1
(en)
|
2022-06-28 |
2023-12-28 |
Illumina Cambridge Limited |
Fluorescent dyes containing fused tetracyclic bis-boron heterocycle and uses in sequencing
|
GB202210861D0
(en)
|
2022-07-25 |
2022-09-07 |
Univ Oxford Innovation Ltd |
Loaded extracellular vesicle
|
WO2024039516A1
(en)
|
2022-08-19 |
2024-02-22 |
Illumina, Inc. |
Third dna base pair site-specific dna detection
|